
Nifedipine Medication Market
Description
Nifedipine Medication Market, By Dosage Form (Tablets, Extended-Release Tablets, Capsules), By Indication (Hypertension, Angina Pectoris, Raynaud\'s Phenomenon), By Distribution Channel (Hospitals and Clinics, Retail Pharmacies, Online Pharmacies), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Nifedipine is a calcium channel blocker that is frequently utilized in the treatment of hypertension (also known as high blood pressure) as well as certain cardiovascular disorders. It includes both branded and generic versions of nifedipine, as well as a variety of dosage forms including tablets, capsules, and extended-release formulations.
Market Dynamics:
A growing number of people suffering from hypertension and cardiovascular illnesses and increasing aging population are major factors expected to drive growth of the global nifedipine medication market during the forecast period.
However, patent expiration, regulatory challenges, adverse effects, availability of alternative treatments, shifting treatment paradigms, pricing pressures are expected to hamper the growth of the global nifedipine medication market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global nifedipine medication market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global nifedipine medication market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer Inc., Novartis AG, Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., Johnson & Johnson, GlaxoSmithKline plc, Lupin Limited , Sun Pharmaceutical Industries Ltd., Sandoz International GmbH (a Novartis division) Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd, Apotex Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global nifedipine medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nifedipine medication market.
- Global Nifedipine Medication Market, By Dosage Form:
- Tablets
- Extended-Release Tablets
- Capsules
- Global Nifedipine Medication Market, By Indication:
- Hypertension
- Angina Pectoris
- Raynaud's Phenomenon
- Global Nifedipine Medication Market, By Distribution Channel:
- Hospitals and Clinics
- Retail Pharmacies
- Online Pharmacies
- Global Nifedipine Medication Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles:
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sanofi S.A.
- Johnson & Johnson
- GlaxoSmithKline plc
- Lupin Limited
- Sun Pharmaceutical Industries Ltd.
- Sandoz International GmbH (a Novartis division)
- Dr. Reddy's Laboratories Ltd.
- Torrent Pharmaceuticals Ltd.
- Apotex Inc.
Table of Contents
160 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- A growing number of people suffering from hypertension and cardiovascular illnesses
- Patent expiration, regulatory challenges, and adverse effects
- Emerging markets, partnerships and collaborations
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Nifedipine Medication Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Nifedipine Medication Market, By Dosage Form, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Extended-Release Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Tablets Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- 6. Global Nifedipine Medication Market, By Indication, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Angina Pectoris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Raynaud's Phenomenon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- 7. Global Nifedipine Medication Market, By Distribution Channel, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
- 8. Global Nifedipine Medication Market, By Region, 2023-2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn)
- 9. Competitive Landscape
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd
- Mylan N.V.
- Sanofi S.A.
- Johnson & Johnson
- GlaxoSmithKline plc
- Lupin Limited
- Sun Pharmaceutical Industries Ltd.
- Sandoz International GmbH (a Novartis division)
- Dr. Reddy's Laboratories Ltd.
- Torrent Pharmaceuticals Ltd.
- Apotex Inc.
- Analyst Views
- 10. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Global Nifedipine Medication Market” - forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.